NPM1 and acute myeloid leukemia: On the other hand, FTO mediated m6A modification also upregulates the expression of the tumour protein p53 inducible nuclear protein 2 (TP53INP2) in the cytoplasm of NPM1 mutated AML cells, which further promotes leukaemia cell survival by enhancing their autophagic activity [103].